Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-Talk.

Saved in:
Bibliographic Details
Title: Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-Talk.
Authors: Greenwood DL; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Ramsey HE; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Nguyen PTT; Department of Cancer Biology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Neuroscience Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Patterson AR; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Voss K; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Bader JE; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Sugiura A; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Bacigalupa ZA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Schaefer S; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Ye X; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Dahunsi DO; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Madden MZ; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN., Wellen KE; Department of Cancer Biology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Savona MR; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN; and.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN., Ferrell PB; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN; and.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN., Rathmell JC; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN; and.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN.
Source: ImmunoHorizons [Immunohorizons] 2022 Dec 01; Vol. 6 (12), pp. 837-850.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101708159 Publication Model: Print Cited Medium: Internet ISSN: 2573-7732 (Electronic) Linking ISSN: 25737732 NLM ISO Abbreviation: Immunohorizons Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2573-7732
DOI:10.4049/immunohorizons.2200086